Company intelligence / Profile preview

QuBEST BIO

Yongin-si (Yongin), Gyeonggi-do, South Koreaqubest.co.kr ↗

Ownership: Private
Development stage: Preclinical

Overview

QuBEST BIO is an established South Korean consulting research organization specializing in pharmaceutical R&D support, including preclinical evaluation, IND/NDA filing support, pharmacology, toxicology, DMPK/bioanalysis services. It has over 18 years of leadership in the field and collaborates with more than 20 foreign CRO sites. The company files 5–7 US FDA INDs per year for clients.

Modalities: Small moleculeBiologic
Industry: Contract Research Organization

Partnerships

Q-fitter (MOU)Unnamed 3D Organoid & AI company (MOU)

Beyond the preview

Go deeper on QuBEST BIO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on QuBEST BIO.

Explore the full profile